Efficacy and toxicity of therapy immediately after treatment with nivolumab in relapsed multiple myeloma.
Leukemia & lymphoma
Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Immunological/adverse effects; Antineoplastic Agents, Immunological/therapeutic use; Combined Modality Therapy/methods; Female; Humans; Male; Middle Aged; Multiple Myeloma/drug therapy; Multiple Myeloma/pathology; Neoplasm Recurrence, Local; Nivolumab/adverse effects; Nivolumab/therapeutic use; Remission Induction; Treatment Outcome
Earle A. Chiles Research Institute
Pianko, Matthew J; Funt, Samuel A; Page, David B; Cattry, Deepika; Scott, Emma C; Ansell, Stephen M; Borrello, Ivan M; Gutierrez, Martin; Lendvai, Nikoletta; Hassoun, Hani; Landgren, C Ola; and Lesokhin, Alexander M, "Efficacy and toxicity of therapy immediately after treatment with nivolumab in relapsed multiple myeloma." (2018). Articles, Abstracts, and Reports. 73.